Zika

Vaccines rely on the induction of adaptive T and B cells responses to confer long term immunity. A potential challenge to inducing protective ZIKV immunity by vaccination, is pre-existing dengue…

10th May 2018 The emergent strain of Zika virus (ZIKV) that caused the 2015-16 outbreak in the Americas, is more virulent than the ZIKV first identified in Uganda. One of…

15th March 2018 Knowledge of Zika virus (ZIKV) immunity in the genital tract is limited. Researchers from Washington University in USA aimed to determine if subcutaneous ZIKV infection protects against…

27th November, 2017Pregnant women are particularly susceptible to symptomatic Zika virus (ZIKV) infection and the virus has the ability to affect the developing fetus, resulting in a host...

25th August, 2017The recent Zika virus (ZIKV) outbreak has highlighted the need for developing ZIKV therapies and vaccines. One of the biggest risks of ZIKV infection in pregnant women is…

21st June, 2017First isolated in Ugandan monkeys, Zika virus (ZIKV) is a primarily vectorborne pathogen carried by certain Aedes mosquitoes. Though recent studies have postulated that ZIKV has been...

Previous studies have shown that Zika virus (ZIKV) persists in certain parts of the body even after the symptoms clear.

16th January, 2017T cells have been found to play an important role in the control of Zika virus as shown by scientist from the La Jolla Institute for Allergy and…